My Companies
Notification
Account
Log Out
Login
Board approved proposal to raise funds up to Rs. 50 crores through permissible modes including rights issue, preferential issue, convertible securities, or warrants, subject to regulatory and shareholder approvals. Specific mode, pricing, and terms to be determined later.
Bacil Pharma Board Approves ₹50 Crore Rights Issue to Existing Shareholders
Niraj Shah Acquires 6.44% Stake in Bacil Pharma via Open Market
Bacil Pharma Non-Promoter Manubhai Shah Sells 2.75% Stake in Two Days
Bacil Pharma Non-Promoter Nikita Patel Sells 7.10% Stake in Two Days